Reuters (1/23, Rapaport) reports, “While only a minority of transgender youth who want puberty-blocking medicines receive this treatment,” research “suggests they may have a lower suicide risk when they get it.”

CNN (1/23, Christensen) reports investigators arrived at this conclusion after “analyzing data from the 2015 US Transgender Survey, involving 20,619 people between the ages of 18 and 36 years old.” The findings were published online Jan. 23 in Pediatrics. Currently, “at least six states are trying to restrict transgender kids from getting gender reassignment treatments.”

Providing similar coverage are Newsweek (1/23, Gander) and MedPage Today (1/23, Monaco).

Related Links:

— “For some trans youth, suicide risk lowers with puberty suppression, “Lisa Rapaport, Reuters, January 23, 2020

Healio (1/23, Gramigna) reports, “Suicide rates vary by industry and occupation, with individuals in specific groups within these categories experiencing higher rates compared with the general population,” CDC researchers concluded in findings published in the Jan. 24 issue of the Morbidity and Mortality Weekly Report. For the study, investigators “analyzed data from 32 states included in the 2016 National Violent Death Reporting System,” with a focus on “suicide data by industry and occupation among working-age decedents presumed to be employed at the time of death.” The study revealed that “male fishing and hunting workers had the highest suicide rate, followed by musicians, singers and related workers,” while “artists and related workers experienced the highest suicide rate among women, followed by laborers and freight, stock and material movers.”

Related Links:

— “CDC: Suicide rates vary widely by industry and occupation, “Joe Gramigna, Healio, January 23, 2020

MD Magazine (1/22, Kunzmann) reports researchers “have observed a link between maternal postpartum depression and a risk of developing atopic dermatitis in childhood and adolescence.” After examining “a database of nearly 5000 US children born in metropolitan areas,” investigators found that “mothers are at a greater rate of depression in the postpartum period and beyond if their child suffers from the common skin condition.” What’s more, “the risk of depression…worsens with the severity or continuance of atopic dermatitis.” The findings were published in the January/February issue of the journal Dermatitis.

Related Links:

— “Postpartum Depression Linked to Pediatric Dermatitis, “Kevin Kunzmann, MD Magazine, January 22, 2020

MD Magazine (1/22, Rosenfeld) reports a study of over 700 women who experienced miscarriage or ectopic pregnancy found that one in six suffered from post-traumatic stress (PTSD). One month after the loss, “29% of women suffered post-traumatic stress and 24% experienced moderate to severe anxiety.” At nine months, the women who experienced ectopic pregnancy demonstrated higher PTSD, anxiety, and depression than those who had a miscarriage. The findings were published in the American Journal of Obstetrics and Gynecology.

Related Links:

— “Miscarriage Associated with High Levels of Post-Traumatic Stress, “Samara Rosenfeld, MD Magazine, January 22, 2020

MedPage Today (1/21, George) reports, “Benzodiazepines continued to be co-prescribed with opioids, despite risks that their concurrent use could lead to fatal overdose,” investigators from the CDC’s National Center for Health Statistics concluded in research (pdf) published online Jan. 17 in the National Health Statistics Reports. The report revealed that “from 2014 to 2016, benzodiazepines were prescribed at approximately 65.9 million office-based physician visits annually,” and “about 23 million (35%) of those office visits also involved an overlapping opioid prescription.” The study also found that “benzodiazepine prescribing rates were highest for women 65 and older,” while “women 65 and older also had the highest rate of co-prescribing, at 19 visits per 100 women.”

Related Links:

— “Opioid-Benzo Co-Prescribing Continues, Despite Risks, “Judy George, MedPage Today, January 21, 2020